Outcomes of Patients With Poorly Differentiated Hepatocellular Carcinoma After Liver Transplantation
详细信息 查看全文
- 作者：M. Krasnodębski<sup> ; sup><sup>mwkrasn@gmail.com" class="auth_mail" title="E-mail the corresponding authorsup> ; M. Grąt ; Ł. Masior ; K.M. Wronka ; K. Grąt ; J. Stypułkowski ; E. Bik ; W. Patkowski ; M. Krawczyk
- 刊名：Transplantation Proceedings
- 出版年：2016
- 出版时间：June 2016
- 年：2016
- 卷：48
- 期：5
- 页码：1713-1716
- 全文大小：362 K
文摘
- ss="listitem" id="list_ulist0010">
- ss="label">•
Patients with poorly differentiated tumors undergoing liver transplantation comprise a heterogeneous group of patients with different prognoses.
- ss="label">•
α-Fetoprotein concentration and tumor size can predict outcomes in patients with G3 tumors before liver transplantation.
- ss="label">•
A group of patients with acceptable survival can be selected from among patients with poorly differentiated hepatocellular carcinoma treated with liver transplantation.